Crossover S.L.P. Sofinnova II reported a 5.4% stake in Hemab Therapeutics Holdings COAG · 2,511,212 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.4%
Last report: First report
Shares held: 2,511,212 sh
Class: Common Stock, par value $0.0001 per share
Stock: Hemab Therapeutics Holdings COAG
Holder: Crossover S.L.P. Sofinnova II
Event date: 26/06/30
Filed: 26/08/05

First 5%+ report · 5.4% stake

Hemab Therapeutics Holdings trades, last 26 weeks

What else happened in Hemab Therapeutics Holdings around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Crossover S.L.P. Sofinnova II's other 5% stake reports

No other trades yet.